Kardium announced today that it raised $250 million in a new financing round to support the launch of its pulsed field ablation system. New investors, including Janus Henderson Investors, Qatar Investment Authority (QIA), MMCAP, Piper Heartland Healthcare Capital, Eventide Asset Management and Eckuity Capital, led the oversubscribed round. … [Read more...] about Kardium raises $250M to support pulsed field ablation system
Kardium
Kardium treats first patient in pulsed-field ablation study
Kardium announced today that it successfully treated the first patients in the PULSAR clinical study for its Globe PF pulsed-field ablation (PFA) system. Vancouver, British Columbia-based Kardium recently received FDA investigational device exemption (IDE) to conduct the study. The international, multicenter PULSAR study evaluates the safety and … [Read more...] about Kardium treats first patient in pulsed-field ablation study
